Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL575201 | 0.91 | CHRM2 (0.41) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| SCHEMBL8154019 | 0.90 | CHRM2 (0.37) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| Clorethate SCHEMBL1409011 | 0.83 | CHRM2 (0.38) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| Phosphonic Acid SCHEMBL8160257 | 0.79 | HTT (0.48) | ALDH1A1 | |
| Phosphonic Acid SCHEMBL8153453 | 0.78 | ALDH1A1 (0.39) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| Clorethate SCHEMBL41346 | 0.77 | CHRM2 (0.39) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 | |
| Phosphonic Acid SCHEMBL8156687 | 0.75 | NAAA (0.36) | ALDH1A1 | |
| SCHEMBL16860591 | 0.72 | SMN1; SMN2 (0.30) | — | |
| SCHEMBL9443410 | 0.72 | MAPK1 (0.37) | ALDH1A1 | |
| SCHEMBL575139 | 0.71 | ALDH1A1 (0.62) | CHRM2CHRM4CHRM1CHRM3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2000510455-A | — | — | 2000-08-15 | — | — | JP | claimed |
| EP-0896540-A1 | USE OF PHOSPHONIC ACID ESTERS FOR THE TREATMENT OF FUNCTIONAL DISORDERS OF THE BRAIN AND DEPRESSION | Troponwerke GmbH & Co. KG (DE) | 1999-02-17 | — | — | EP | claimed |
| EP-0896540-A1 | USE OF PHOSPHONIC ACID ESTERS FOR THE TREATMENT OF FUNCTIONAL DISORDERS OF THE BRAIN AND DEPRESSION | Troponwerke GmbH & Co. KG (DE) | 1999-02-17 | — | — | EP | disclosed |